Inhibition of NF-κB in T cells blocks lymphoproliferation and partially rescues autoimmune disease in gld/gld mice

European Journal of Immunology

Volumn 31, Issue 9, 2001, Pages 2612-2622

  Vallabhapurapu, Sivakumar ^a   Ryseck, Rolf Peter ^a   Malewicz, Michal ^a   Weih, Debra S ^a   Weih, Falk ^a,b  

^a KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

^b BRISTOL MYERS SQUIBB   (United States)

Author keywords

Fas ligand; Generalized lymphoproliferative disorder; I B ; Lymphadenopathy; Transgenic

Indexed keywords

AUTOANTIBODY; CD4 ANTIGEN; CD8 ANTIGEN; FAS ANTIGEN; FAS LIGAND; IMMUNOGLOBULIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR; DNA BINDING PROTEIN; FASL PROTEIN, MOUSE; I KAPPA B; LYMPHOCYTE ANTIGEN RECEPTOR; MEMBRANE PROTEIN; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CELL SPECIFICITY; CELL SURVIVAL; CONTROLLED STUDY; DEATH; GLOMERULONEPHRITIS; HOMEOSTASIS; IMMUNE SYSTEM; IMMUNOGLOBULIN BLOOD LEVEL; LYMPHADENOPATHY; LYMPHOCYTE PROLIFERATION; MOUSE; MOUSE MUTANT; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SPLENOMEGALY; T LYMPHOCYTE; TRANSGENE; ANIMAL; CELL CULTURE; DRUG ANTAGONISM; GENETICS; IMMUNOLOGY; LYMPHATIC SYSTEM DISEASE; LYMPHOCYTE ACTIVATION; LYMPHOPROLIFERATIVE DISEASE; MEMBRANOUS GLOMERULONEPHRITIS; METABOLISM; TRANSGENIC MOUSE;

ANIMALS; APOPTOSIS; CELLS, CULTURED; DNA-BINDING PROTEINS; FAS LIGAND PROTEIN; GLOMERULONEPHRITIS, MEMBRANOUS; I-KAPPA B PROTEINS; LYMPHATIC DISEASES; LYMPHOCYTE ACTIVATION; LYMPHOPROLIFERATIVE DISORDERS; MEMBRANE GLYCOPROTEINS; MICE; MICE, TRANSGENIC; NF-KAPPA B; RECEPTORS, ANTIGEN, T-CELL; SPLENOMEGALY; T-LYMPHOCYTES;

EID: 0034741071     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200109)31:9<2612::AID-IMMU2612>3.0.CO;2-C     Document Type: Article

References (51)

1. Die and let live: Eliminating dangerous lymphocytes
2. CD95's deadly mission in the immune system
3. Expression of the Fas ligand in cells of T cell lineage
4. CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway
5. Expression and function of Fas antigen on activated murine B cells
6. Apoptosis by death factor
7. Lpr and gld: Single gene models of systemic autoimmunity and lymphoproliferative disease
8. Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice
9. Generalized lymphoproliferative disease in mice caused by a point mutation in the Fas ligand
10. The Fas death factor
11. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity
12. Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease
13. Clinical, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis
14. Transgenic T cell receptor interactions in the lymphoproliferative and autoimmune syndromes of lpr and gld mutant mice
15. Selection of the T cell receptor repertoire in Lpr mice
16. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T cell hybridomas
17. Autocrine T cell suicide mediated by APO-1/(Fas/CD95)
18. Fas(CD95)/FasL interactions required for programmed cell death after T cell activation
19. Mature T cells of autoimmune lpr/lpr mice have a defect in antigen-stimulated suicide
20. Autoimmune gld mutation uncouples suicide and cytokine/proliferation pathways in activated, mature T cells
21. Function and activation of NF-κB in the immune system
22. Control of apoptosis by Rel/NF-κB transcription factors
23. NF-κB and Rel proteins: Evolutionarily conserved mediators of immune responses
24. How NF-κB is activated: The role of the κB kinase (IKK) complex
25. Activators and target genes of Rel/NF-κB transcription factors
26. Constitutive NF-κB activation, enhanced granulopoiesis, and neonatal lethality in κBα-deficient mice
27. Perturbation of the T lymphocyte lineage in transgenic mice expressing a constitutive repressor of nuclear factor (NF)-κB
28. In vivo inhibition of NF-κB in T-lineage cells leads to a dramatic decrease in cell proliferation and cytokine production and to increased cell apoptosis in response to mitogenic stimuli, but not to abnormal thymopoiesis
29. An essential role for nuclear factor κB in promoting double positive thymocyte apoptosis
30. Overexpression of RelB in transgenic mice does not affect lκBα levels: Differential regulation of RelA and RelB by the inhibitor protein
31. Phenotypic abnormalities of splenic and bone marrow B cells in lpr and gld mice
32. Chronic treatment of C3H-lpr/lpr and C3H-gld/gld mice with anti-CD8 monoclonal antibody prevents the accumulation of double negative T cells but not autoantibody production
33. Correction of accelerated autoimmune disease by early replacement of the mutated lpr gene with the normal Fas apoptosis gene in the T cells of transgenic MRL-lpr/lpr mice
34. + cells and autoimmunity
35. Transgenic expression of Fas in T cells blocks lymphoproliferation but not autoimmune disease in MRL-lpr mice
36. + T cells to lymphoproliferation and autoantibody production in MRL-lpr/lpr mice
37. Anti-CD4 monoclonal antibody therapy suppresses autoimmune disease in MRL/Mp-lpr/lpr mice
38. + T cells but normal autoantibody production in lpr/lpr mice lacking major histocompatibility complex class I molecules
39. NF-κB regulates Fas/APO-1/CD95- and TCR-mediated apoptosis of T lymphocytes
40. Tumor necrosis factor sustains the generalized lymphoproliferative disorder (gld) phenotype
41. + T cells
42. Induction of apoptosis in mature T cells by tumour necrosis factor
43. Thymic expression of the transcription factor Nur77 rescues the T cell but not the B cell abnormality of gld/gld mice
44. An intrinsic B cell defect is required for the production of autoantibodies in the lpr model of murine systemic autoimmunity
45. Inhibition of abnormal T cell development and autoimmunity in gld mice by transgenic T cell receptor β chain
46. Ipr T cells are necessary for autoantibody production in lpr mice
47. Balancing immunity and tolerance: Deleting and tuning lymphocyte repertoires
48. Rapid and efficient site-specific mutagenesis without phenotypic selection
49. Apoptosis of nur77/N10-transgenic thymocytes involves the Fas/Fas ligand pathway
50. Constitutive and inducible Rel/NF-κB activities in mouse thymus and spleen
51. Covalent immobilization of DNA onto polystyrene microwells: The molecules are only bound at the 5′ end